|
|
News Breaks
|
October 20, 2009
|
| 09:13 EDT |  | HEPH |
| theflyonthewall.com: | Hollis-Eden retains Burrill LLC for advisory services | | Hollis-Eden Pharmaceuticals has retained Burrill LLC to provide exclusive strategic advisory services, with an initial focus on partnering Hollis-Eden's lead program Apoptone, currently in Phase I/II development for hormone-refractory prostate cancer. :theflyonthewall.com |
|
|
News For HEPH From The Last 14 Days Check below for free stories on HEPH the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
